Evidence map›Paper›PMID 29676281›Full record

ArticleLancet (London, England)2018

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.

Angela M Wood, Stephen Kaptoge, Adam S Butterworth, Peter Willeit, Samantha Warnakula, Thomas Bolton, Ellie Paige, Dirk S Paul, Michael Sweeting, Stephen Burgess and 111 more

Erratum issuedAbstract read
In one paragraph

Article in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 583 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
583citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

583 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Alcohol consumption and heart failure: a dose-response meta-analysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Review

523 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

121 authors.

Angela M WoodDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK. Electronic address: amw79@medschl.cam.ac.uk.
Stephen KaptogeDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Adam S ButterworthDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Peter WilleitDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Medical University Innsbruck, Innsbruck, Austria.
Samantha WarnakulaDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Thomas BoltonDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ellie PaigeNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
Dirk S PaulDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Michael SweetingDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Stephen BurgessDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK; MRC Biostatistics Unit, Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Steven BellDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
William AstleDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
David StevensDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Albert KoulmanNIHR BRC Nutritional Biomarker Laboratory, University of Cambridge, Cambridge, UK.
Randi M SelmerNorwegian Institute of Public Health, Oslo, Norway.
W M Monique VerschurenNational Institute for Public Health and the Environment, Bilthoven, Netherlands; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Shinichi SatoChiba Prefectural Institute of Public Health, Chiba, Japan.
Inger NjølstadDepartment of Community Medicine, University of Tromsø, Tromsø, Norway.
Mark WoodwardNuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, UK; The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Veikko SalomaaTHL-National Institute for Health and Welfare, Helsinki, Finland.
Børge G NordestgaardCopenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Bu B YeapSchool of Medicine, University of Western Australia, Perth, WA, Australia; Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, Perth, WA, Australia.
Astrid FletcherLondon School of Hygiene & Tropical Medicine, London, UK.
Olle MelanderDepartment of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
Lewis H KullerGraduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Beverley BalkauCESP INSERM UMRS 1018, Villejuif Cedex, France.
Michael MarmotDepartment of Epidemiology and Public Health, University College London, London, UK.
Wolfgang Koenig92 Deutsches Herzzentrum München, Technische Universität München, Munich, Germany, DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; University of Ulm Medical Center, Ulm, Germany.
Edoardo CasigliaDepartment of Medicine, University of Padua, Padua, Italy.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Volker ArndtGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Oscar H FrancoErasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
Patrik WennbergDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
John GallacherDepartment of Primary Care and Public Health, Cardiff University, Cardiff, UK.
Agustín Gómez de la Cámara12 de Octubre Research Institute, CIBERESP, Madrid, Spain.
Henry VölzkeInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Caroline E DaleFarr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London, UK.
Manuela M BergmannGerman Institute of Human Nutrition, Potsdam-Rehbrüke, Germany.
Carlos J CrespoSchool of Community Health, Portland State University, Portland, OR, USA.
Yvonne T van der SchouwJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Rudolf KaaksGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Leon A SimonsSt Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pagona LagiouHellenic Health Foundation, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece; Harvard TH Chan School of Public Health, Boston, MA, USA.
Josje D SchoufourErasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
Jolanda M A BoerNational Institute for Public Health and the Environment, Bilthoven, Netherlands.
Timothy J KeyNuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, UK.
Beatriz RodriguezOffice of Public Health Studies, University of Hawaii, Honolulu, HI, USA.
Conchi Moreno-IribasInstituto de Salud Pública de Navarra, IdiSNA - Navarra Institute for Health Research, Pamplona, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain.
Karina W DavidsonColumbia University Irving Medical Center, New York, NY, USA.
James O TaylorEast Boston Neighborhood Health Center, Boston, MA, USA.
Carlotta SacerdoteCittà della Salute e della Scienza di Torino Hospital, Turin, Italy.
Robert B WallaceCollege of Public Health, The University of Iowa, Iowa City, IA, USA.
J Ramon QuirosConsejería de Sanidad del Principado de Asturias, Oviedo, Asturias, Spain.
Rosario TuminoCivic - M. Arezzo Hospital, ASP Ragusa, Italy.
Dan G BlazerDuke Divinity School, Duke University, Durham, NC, USA.
Allan LinnebergDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Makoto DaimonGlobal Center of Excellence Program Study Group, Yamagata University Faculty of Medicine, Yamagata, Japan.
Salvatore PanicoDepartment of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Barbara HowardDepartment of Biology, Tuskegee University, AL, USA.
Guri SkeieDepartment of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Timo StrandbergUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland; Center for Life Course Health Research, University of Oulu, Oulu, Finland.
Elisabete WeiderpassDepartment of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Paul J NietertMedical University of South Carolina, Charleston, SC, USA.
Bruce M PsatyCardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, WA, USA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Daan KromhoutDepartment of Agrotechnology and Food Sciences, University of Wageningen, Wageningen, Netherlands; Faculty of Medical Sciences, University of Groningen, Groningen, Netherlands.
Elena Salamanca-FernandezEscuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Stefan KiechlMedical University Innsbruck, Innsbruck, Austria.
Harlan M KrumholzSchool of Medicine, Yale University, New Haven, CT, USA.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Domenico PalliCancer Research and Prevention Institute (ISPO), Florence, Italy.
José M HuertaCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Jackie PriceUsher Institute, University of Edinburgh, Edinburgh, UK.
Johan SundströmDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Larraitz ArriolaCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Instituto BIO-Donostia, Basque Government, San Sebastian, Spain.
Hisatomi ArimaThe University of Sydney and Royal Prince Alfred Hospital, Sydney, NSW, Australia; Department of Preventive Medicine and Public Health, Kyushu University, Fukuoka, Japan.
Ruth C TravisNuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, UK.
Demosthenes B PanagiotakosSchool of Health Science and Education, Harokopio University, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece.
Tilman KühnGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Diederick E GrobbeeJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Elizabeth Barrett-ConnorDepartment of Family Medicine and Public Health, University of California, San Diego, CA, USA.
Natasja van SchoorEMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.
Heiner BoeingGerman Institute of Human Nutrition, Potsdam-Rehbrüke, Germany.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark; Aalborg University Hospital, Aalborg, Denmark.
Jussi KauhanenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Nick WarehamMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK.
Claudia LangenbergMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK.
Nita ForouhiMedical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK.
Maria WennbergDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Jean-Pierre DesprésDepartment of Kinesiology, Laval University, Quebec City, QC, Canada.
Mary CushmanDepartment of Medicine, University of Vermont, Burlington, VT, USA.
Jackie A CooperDepartment of Epidemiology and Public Health, University College London, London, UK.
Carlos J RodriguezWake Forest University School of Medicine, Winston-Salem, NC, USA; Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Masaru SakuraiDepartment of Social and Environmental Medicine, Kanazawa Medical University, Ishikawa, Japan.
Jonathan E ShawBaker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.
Matthew KnuimanBusselton Population Medical Research Institute, Busselton, WA, Australia; School of Population and Global Health, The University of Western Australia, Perth, WA, Australia.
Trudy VoortmanErasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
Christa MeisingerHelmholtz Zentrum München German Research Center for Environmental Health, Germany.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Hermann BrennerGerman Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Clinical Epidemiology and Aging Research, University of Heidelberg, Heidelberg, Germany.
Luigi PalmieriIstituto Superiore di Sanità, Rome, Italy.
Jean DallongevilleInstitut Pasteur de Lille, Lille, France.
Eric J BrunnerDepartment of Epidemiology and Public Health, University College London, London, UK.
Gerd AssmannAssmann-Stiftung für Prävention, Münster, Germany.
Maurizio TrevisanThe City College of New York, New York, NY, USA.
Richard F GillumHoward University Hospital, Washington DC, USA.
Ian FordInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
Naveed SattarInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
Mariana LazoSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Simon G ThompsonDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Pietro FerrariInternational Agency for Research on Cancer, Lyon, France.
David A LeonLondon School of Hygiene & Tropical Medicine, London, UK.
George Davey SmithMRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
Richard PetoNuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, UK.
Rod JacksonSchool of Population Health, The University of Auckland, Auckland, New Zealand.
Emily BanksNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.
Emanuele Di AngelantonioDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
John DaneshDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK. Electronic address: jd292@medschl.cam.ac.uk.
Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group

Funding

Wake Forest Field CenterU10AA025286 · NIAAA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LAZO ELIZONDO, MARIANA · 2016 to 2017
$11.4M
British Heart Foundation CH/12/2/29428British Heart Foundation RG/13/13/30194British Heart Foundation RG/16/11/32334Cancer Research UK 16491European Research Council 268834Medical Research Council G0400491Medical Research Council G0700463Medical Research Council G0701619Medical Research Council G0800270Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_00002/7Medical Research Council MC_UU_00011/1Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12012/5Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Medical Research Council MR/K013351/1Medical Research Council MR/K014811/1Medical Research Council MR/L003120/1Medical Research Council MR/N003284/1Medical Research Council MR/R024227/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P001076/1NIAAA NIH HHS U10 AA025286Wellcome Trust 204623/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

backgroundLow-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease.

methodsWe did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12·5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5·6 years [5th-95th percentile 1·04-13·5]) from 71 011 participants from 37 studies.

findingsIn the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5·4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1·14, 95% CI, 1·10-1·17), coronary disease excluding myocardial infarction (1·06, 1·00-1·11), heart failure (1·09, 1·03-1·15), fatal hypertensive disease (1·24, 1·15-1·33); and fatal aortic aneurysm (1·15, 1·03-1·28). By contrast, increased alcohol consumption was log-linearly associated with a lower risk of myocardial infarction (HR 0·94, 0·91-0·97). In comparison to those who reported drinking >0-≤100 g per week, those who reported drinking >100-≤200 g per week, >200-≤350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1-2 years, or 4-5 years, respectively.

interpretationIn current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines.

fundingUK Medical Research Council, British Heart Foundation, National Institute for Health Research, European Union Framework 7, and European Research Council.

Indexed as

Alcohol DrinkingCardiovascular DiseasesFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID29676281
PMCPMC5899998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.